PTP1B overexpression is strictly related to insulin resistance, and it has been demonstrated that the inhibition or genetic ablation of this phosphatase can improve glucose homeostasis, cellular sensitivity to both insulin and leptin, and resistance to diet-induced obesity, all without inducing hypoglycemia or toxic effects. The gene discussed is LEP; the disease is Hypoglycemia.